Table 1.
The risk score was associated with the Gleason score, T stage, and N stage of patients with PCa in the training set
| Total (N = 404) |
Expression | P-value | ||
|---|---|---|---|---|
| High_risk (N = 202) |
Low_risk (N = 202) |
|||
| Gleason_Score | ||||
| 6 | 23 (5.7%) | 7 (3.5%) | 16 (7.9%) | 0.005 |
| 7 | 201 (49.8%) | 87 (43.1%) | 114 (56.4%) | |
| 8 | 57 (14.1%) | 32 (15.8%) | 25 (12.4%) | |
| 9 | 120 (29.7%) | 74 (36.6%) | 46 (22.8%) | |
| 10 | 3 (0.7%) | 2 (1.0%) | 1 (0.5%) | |
| Age (years) | ||||
| > = 55 | 62 (15.3%) | 25 (12.4%) | 37 (18.3%) | 0.129 |
| < 55 | 342 (84.7%) | 177 (87.6%) | 165 (81.7%) | |
| pT | ||||
| T2 | 140 (34.7%) | 50 (24.8%) | 90 (44.6%) | < 0.001 |
| T3 | 254 (62.9%) | 144 (71.3%) | 110 (54.5%) | |
| T4 | 10 (2.5%) | 8 (4.0%) | 2 (1.0%) | |
| pN | ||||
| N0 | 330 (81.7%) | 150 (74.3%) | 180 (89.1%) | < 0.001 |
| N1 | 74 (18.3%) | 52 (25.7%) | 22 (10.9%) | |